Form D · Other
S2N Health Inc.
Boston, MA · CIK 0001983054
Offering snapshot reported Jun 2, 2026 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2026 | Initial | $3,000,000 | No comparison | 25 | SEC filing |
| Jun 5, 2025 | Amendment | $4,314,787 | $1,204,789vs May 23, 2024 | 34 | SEC filing |
| May 23, 2024 | Initial | $3,109,998 | No comparison | 21 | SEC filing |
| Jun 26, 2023 | Initial | $150,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585919
Convertible Promissory Notes
Source: Form D, filed Jun 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roome Hugh | Director |
| Timothy Kofol | Director, Executive |
| Andrew Schwab | Director |
| Martha Shadan | Director |
| Amy Siegel | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
50 Milk Street 16 Th Floor
Boston, MA, 02109
Boston, MA, 02109